Battelino T - Search Results

1

Efficacy of once-weekly tirzepatide versus once-daily insulin degludec on glycaemic control measured by continuous glucose monitoring in adults with type 2 diabetes (SURPASS-3 CGM): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial.

Battelino T, Bergenstal RM, Rodríguez A, Fernández Landó L, Bray R, Tong Z, Brown K. Battelino T, et al. Lancet Diabetes Endocrinol. 2022 Jun;10(6):407-417. doi: 10.1016/S2213-8587(22)00077-8. Epub 2022 Apr 22. Lancet Diabetes Endocrinol. 2022. PMID: 35468321 Clinical Trial.

2

The use of continuous subcutaneous insulin infusion (CSII) as the treatment of choice in children and adolescents with type 1 diabetes.

Battelino T, Ursic-Bratina N, Bratanic N, Zerjav-Tansek M, Avbelj M, Krzisnik C. Battelino T, et al. Pediatr Endocrinol Rev. 2004 Aug;1 Suppl 3:537-9. Pediatr Endocrinol Rev. 2004. PMID: 16444189

3

Risk and benefits of continuous subcutaneous insulin infusion (CSII) treatment in school children and adolescents.

Battelino T. Battelino T. Pediatr Diabetes. 2006 Aug;7 Suppl 4:20-4. doi: 10.1111/j.1399-543X.2006.00167.x. Pediatr Diabetes. 2006. PMID: 16774614 Review.

4

Clinical use of real-time continuous glucose monitoring.

Battelino T, Bolinder J. Battelino T, et al. Curr Diabetes Rev. 2008 Aug;4(3):218-22. doi: 10.2174/157339908785294352. Curr Diabetes Rev. 2008. PMID: 18690903 Review.

5

Continuous glucose monitoring.

Bode BW, Battelino T. Bode BW, et al. Among authors: battelino t. Int J Clin Pract Suppl. 2010 Feb;(166):11-5. doi: 10.1111/j.1742-1241.2009.02272.x. Int J Clin Pract Suppl. 2010. PMID: 20377658 Review.

6

Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes.

Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, Joyce C, Peoples T, Perkins BA, Welsh JB, Willi SM, Wood MA; STAR 3 Study Group. Bergenstal RM, et al. N Engl J Med. 2010 Jul 22;363(4):311-20. doi: 10.1056/NEJMoa1002853. Epub 2010 Jun 29. N Engl J Med. 2010. PMID: 20587585 Free article. Clinical Trial.

7

Real-time continuous glucose monitoring in randomized control trials.

Battelino T, Phillip M. Battelino T, et al. Pediatr Endocrinol Rev. 2010 Aug;7 Suppl 3:401-4. Pediatr Endocrinol Rev. 2010. PMID: 20877253 Review.

8

Insulin pumps and continuous glucose monitoring (CGM) in preschool and school-age children: how schools can integrate technology.

Bratina N, Battelino T. Bratina N, et al. Among authors: battelino t. Pediatr Endocrinol Rev. 2010 Aug;7 Suppl 3:417-21. Pediatr Endocrinol Rev. 2010. PMID: 20877256 Review.

9

Continuous glucose monitoring in 2010.

Battelino T, Bode BW. Battelino T, et al. Int J Clin Pract Suppl. 2011 Feb;(170):10-5. doi: 10.1111/j.1742-1241.2010.02573.x. Int J Clin Pract Suppl. 2011. PMID: 21323807 Review.

10

Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes.

Battelino T, Phillip M, Bratina N, Nimri R, Oskarsson P, Bolinder J. Battelino T, et al. Diabetes Care. 2011 Apr;34(4):795-800. doi: 10.2337/dc10-1989. Epub 2011 Feb 19. Diabetes Care. 2011. PMID: 21335621 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

377 results

Search Page